Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center.

about

Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center.

Item

http://www.wikidata.org/entity/Q40438036

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Outcomes of allogeneic stem ce ...... n Comprehensive Cancer Center.

@en

type

Item

label

Outcomes of allogeneic stem ce ...... n Comprehensive Cancer Center.

@en

prefLabel

Outcomes of allogeneic stem ce ...... n Comprehensive Cancer Center.

@en

P1476

Outcomes of allogeneic stem ce ...... n Comprehensive Cancer Center.

@en

P2093

António Campos-Júnior

http://www.w3.org/2001/XMLSchema#string

Carlos Pinho-Vaz

http://www.w3.org/2001/XMLSchema#string

Fernando Campilho

http://www.w3.org/2001/XMLSchema#string

Maria Rosales

http://www.w3.org/2001/XMLSchema#string

Ramon Andrade Bezerra De-Mello

http://www.w3.org/2001/XMLSchema#string

Rosa Branca

http://www.w3.org/2001/XMLSchema#string

Susana Roncon

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results.

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view.

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an American view.

Biology and management of relapsed acute myeloid leukaemia.

Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.

Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.

P304

641-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1806-9282.62.07.641

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27925043

http://www.w3.org/2001/XMLSchema#string